Avantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.
- Revenue
- +4.59%
- EPS
- +128.9%
- Free cash flow
- −9.03%
- Total debt
- −4.51%
Quarter to September 2026, against a year earlier
Follow AVTR
Alert me
Avantor, Inc. (AVTR) Return on assets
Avantor, Inc.'s return on assets over the twelve months to 30 September 2026 was 2.89%, up 7.3 percentage points from fiscal 2025 (−4.44%). Over the past ten years it has ranged from −73.1% (fiscal 2017) to 5.67% (fiscal 2024); the current reading is higher than 30% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −4.44% | (10.11) |
| FY2024 | 5.67% | 3.24 |
| FY2023 | 2.43% | (2.41) |
| FY2022 | 4.84% | 0.57 |
| FY2021 | 4.27% | 3.74 |
| FY2020 | 0.53% | 3.93 |
| FY2019 | −3.40% | 3.05 |
| FY2018 | −6.45% | 66.60 |
| FY2017 | −73.1% | (72.32) |
| FY2016 | −0.73% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| ALGN Align Technology, Inc. compare | 7.71% |
| ATR AptarGroup, Inc. compare | 5.23% |
| COO The Cooper Companies, Inc. compare | 4.55% |
| AVTR Avantor, Inc. | 2.89% |
| SOLV Solventum Corporation compare | 1.11% |
| RGEN Repligen Corporation compare | −0.40% |
| BLCO Bausch + Lomb Corporation compare | −0.80% |
| BAX Baxter International Inc. compare | −3.57% |
| TFX Teleflex Incorporated compare | −14.6% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on AVTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement